• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基质金属蛋白酶与肝纤维化(转化医学相关)。

Matrix metalloproteinases and liver fibrosis (translational aspects).

机构信息

Department of Gastroenterology, Justus-Liebig-University, Giessen, Germany.

出版信息

Matrix Biol. 2018 Aug;68-69:463-473. doi: 10.1016/j.matbio.2017.12.012. Epub 2017 Dec 28.

DOI:10.1016/j.matbio.2017.12.012
PMID:29289644
Abstract

Liver fibrosis, a reversible wound-healing response to chronic cellular injury, reflects a balance between liver repair and progressive substitution of the liver parenchyma by scar tissue. Complex mechanisms that underlie liver fibrogenesis are summarized to provide the basis for generating targeted therapies to reverse fibrogenesis and improve the outcomes of patients with chronic liver disease. This minireview presents some pathophysiological aspects of liver fibrosis as a dynamic process and elucidates matrix metalloproteinases (MMPs) and their role within as well as beyond matrix degradation. Open questions remain, whether inhibition of fibrogenesis or induction of fibrolysis is the key mechanism to resolve fibrosis. And a point of principle might be whether regeneration of liver cirrhosis is possible. Will we ever cure fibrosis?

摘要

肝纤维化是一种对慢性细胞损伤的可逆转的伤口愈合反应,反映了肝脏修复和瘢痕组织对肝脏实质进行渐进性替代之间的平衡。总结了肝纤维化发生的复杂机制,为开发靶向治疗以逆转肝纤维化和改善慢性肝病患者的预后提供了依据。这篇综述介绍了肝纤维化作为一个动态过程的一些病理生理学方面,并阐明了基质金属蛋白酶(MMPs)及其在基质降解内外的作用。目前仍存在一些悬而未决的问题,例如抑制纤维化或诱导纤维溶解是否是解决纤维化的关键机制。一个原则性的问题可能是肝硬化的再生是否有可能。我们能治愈纤维化吗?

相似文献

1
Matrix metalloproteinases and liver fibrosis (translational aspects).基质金属蛋白酶与肝纤维化(转化医学相关)。
Matrix Biol. 2018 Aug;68-69:463-473. doi: 10.1016/j.matbio.2017.12.012. Epub 2017 Dec 28.
2
Matrix metalloproteinase functions in hepatic injury and fibrosis.基质金属蛋白酶在肝损伤和纤维化中的作用。
Matrix Biol. 2018 Aug;68-69:452-462. doi: 10.1016/j.matbio.2017.11.011. Epub 2017 Dec 6.
3
Mechanisms of fibrinolysis in chronic liver injury (with special emphasis on MMPs and TIMPs).慢性肝损伤中的纤维蛋白溶解机制(特别强调基质金属蛋白酶和组织金属蛋白酶抑制剂)。
Z Gastroenterol. 2007 Jan;45(1):25-33. doi: 10.1055/s-2006-927388.
4
Expression of MMPs and TIMPs in liver fibrosis - a systematic review with special emphasis on anti-fibrotic strategies.基质金属蛋白酶和金属蛋白酶组织抑制因子在肝纤维化中的表达——一项特别关注抗纤维化策略的系统评价
J Hepatol. 2007 May;46(5):955-75. doi: 10.1016/j.jhep.2007.02.003. Epub 2007 Mar 5.
5
Fibrogenesis II. Metalloproteinases and their inhibitors in liver fibrosis.纤维化生成II. 肝纤维化中的金属蛋白酶及其抑制剂
Am J Physiol Gastrointest Liver Physiol. 2000 Aug;279(2):G245-9. doi: 10.1152/ajpgi.2000.279.2.G245.
6
Matrix metalloproteinases in liver injury, repair and fibrosis.基质金属蛋白酶在肝损伤、修复及纤维化中的作用
Matrix Biol. 2015 May-Jul;44-46:147-56. doi: 10.1016/j.matbio.2015.01.004. Epub 2015 Jan 16.
7
Identifying Novel Targets for Treatment of Liver Fibrosis: What Can We Learn from Injured Tissues which Heal Without a Scar?确定肝纤维化治疗的新靶点:我们能从无瘢痕愈合的损伤组织中学到什么?
Curr Drug Targets. 2015;16(12):1332-46. doi: 10.2174/1389450116666150825111439.
8
Reversibility of hepatic fibrosis: from the first report of collagenase in the liver to the possibility of gene therapy for recovery.肝纤维化的可逆性:从肝脏中胶原酶的首次报道到基因治疗恢复的可能性。
Keio J Med. 2001 Jun;50(2):58-65. doi: 10.2302/kjm.50.58.
9
Time profiles of the expression of metalloproteinases, tissue inhibitors of metalloproteases, cytokines and collagens in hamsters infected with Opisthorchis viverrini with special reference to peribiliary fibrosis and liver injury.感染华支睾吸虫的仓鼠中金属蛋白酶、金属蛋白酶组织抑制剂、细胞因子和胶原的时间表达谱,特别是与胆小管周围纤维化和肝损伤的关系。
Int J Parasitol. 2009 Jun;39(7):825-35. doi: 10.1016/j.ijpara.2008.12.002. Epub 2009 Jan 3.
10
Resolving fibrosis in the diseased liver: translating the scientific promise to the clinic.解决患病肝脏中的纤维化问题:将科学前景转化为临床实践。
Int J Biochem Cell Biol. 2007;39(4):695-714. doi: 10.1016/j.biocel.2006.10.006. Epub 2006 Oct 7.

引用本文的文献

1
β-Caryophyllene Ameliorates Thioacetamide-Induced Liver Fibrosis in Rats: A Preventative Approach.β-石竹烯改善硫代乙酰胺诱导的大鼠肝纤维化:一种预防性方法。
Int J Mol Sci. 2025 Sep 1;26(17):8493. doi: 10.3390/ijms26178493.
2
Development and Validation of a Scaffold-Free Human Multilineage Spheroid Model for Early Stage Cholangiopathies Driven by Cholangiocyte Senescence.用于胆管细胞衰老驱动的早期胆管疾病的无支架人类多谱系球体模型的开发与验证
Liver Int. 2025 Oct;45(10):e70352. doi: 10.1111/liv.70352.
3
Novel partial common bile duct ligation procedure in rats with reduced mortality and delayed onset of cirrhosis.
大鼠新型部分胆总管结扎术,死亡率降低且肝硬化发病延迟
Exp Ther Med. 2025 Jul 3;30(3):167. doi: 10.3892/etm.2025.12917. eCollection 2025 Sep.
4
Mechanism-guided drug development and treatment for liver fibrosis: a clinical perspective.机制导向的肝纤维化药物研发与治疗:临床视角
Front Pharmacol. 2025 May 26;16:1574385. doi: 10.3389/fphar.2025.1574385. eCollection 2025.
5
Mechanistic evaluation of a traditional herbal decoction in attenuating hepatic fibrosis via Nrf2/GPX4 pathway activation and ferroptosis inhibition.一种传统草药汤剂通过激活Nrf2/GPX4通路和抑制铁死亡减轻肝纤维化的机制评估
Hereditas. 2025 Jun 9;162(1):100. doi: 10.1186/s41065-025-00471-y.
6
The Wnt/β-Catenin Inhibitor HC-1 Suppresses Liver Fibrosis by Inhibiting Activated Hepatic Stellate Cells and Inducing Matrix Metalloproteinase-1.Wnt/β-连环蛋白抑制剂HC-1通过抑制活化的肝星状细胞和诱导基质金属蛋白酶-1来抑制肝纤维化。
Yonago Acta Med. 2025 May 17;68(2):131-143. doi: 10.33160/yam.2025.05.009. eCollection 2025 May.
7
Development of SOCS1 mimetics as novel approach to harmonize inflammation, oxidative stress, and fibrogenesis in metabolic dysfunction-associated steatotic liver disease.开发SOCS1模拟物作为协调代谢功能障碍相关脂肪性肝病中炎症、氧化应激和纤维化形成的新方法。
Redox Biol. 2025 Jul;84:103670. doi: 10.1016/j.redox.2025.103670. Epub 2025 May 11.
8
Zymography: A Simple and Powerful Tool for the Assessment of MMP-2 and MMP-9 in Pathological Conditions.酶谱法:一种用于评估病理状况下MMP - 2和MMP - 9的简单而强大的工具。
Methods Mol Biol. 2025;2918:187-199. doi: 10.1007/978-1-0716-4482-9_15.
9
[Fibrotic diseases in the gastrointestinal tract : Liver fibrosis and more].[胃肠道纤维化疾病:肝纤维化及其他]
Inn Med (Heidelb). 2025 Mar 3. doi: 10.1007/s00108-025-01869-6.
10
Cigarette Smoke Contributes to the Progression of MASLD: From the Molecular Mechanisms to Therapy.香烟烟雾促进代谢相关脂肪性肝病的进展:从分子机制到治疗
Cells. 2025 Feb 4;14(3):221. doi: 10.3390/cells14030221.